Janssen v. Celtrion Update: Federal Circuit Grants Janssen’s Motion for 30-Day Extension

Janssen v. Celltrion (infliximab)  •  U.S. Federal Circuit Decisions

The Federal Circuit, over Celltrion’s opposition, has granted Janssen’s motion for a 30-day extension of time to file its opening appeal brief.  Janssen’s opening brief is now due on January 26, 2017.

 

Continue following Big Molecule Watch for more updates.

Download PDF

Comments are closed.